N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014839 |
| CAS No | NA |
| Mol.F. | C12H16N4O3S |
| Mol.Wt. | 296.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014840 |
| CAS No | NA |
| Mol.F. | C28H30N6O9 |
| Mol.Wt. | 594.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014841 |
| CAS No | NA |
| Mol.F. | C22H20N4O8 |
| Mol.Wt. | 468.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014842 |
| CAS No | NA |
| Mol.F. | C19H17ClN4O6S |
| Mol.Wt. | 464.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014843 |
| CAS No | NA |
| Mol.F. | C12H16N4O5 |
| Mol.Wt. | 296.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014844 |
| CAS No | NA |
| Mol.F. | C13H16ClN3O4 |
| Mol.Wt. | 313.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014845 |
| CAS No | NA |
| Mol.F. | C20H22ClN5O6S |
| Mol.Wt. | 495.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014846 |
| CAS No | NA |
| Mol.F. | C10H11N3O6 |
| Mol.Wt. | 269.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014847 |
| CAS No | NA |
| Mol.F. | C10H13N3O4 |
| Mol.Wt. | 239.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014848 |
| CAS No | NA |
| Mol.F. | C7H13N3O : C2HF3O2 |
| Mol.Wt. | 155.2 : 114.0 |
| INV STATUS | In Stock |
| CAT No | SRC-N014849 |
| CAS No | NA |
| Mol.F. | C7H13N3O : C2HF3O2 |
| Mol.Wt. | 155.2 : 114.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014850 |
| CAS No | NA |
| Mol.F. | C14H15N3O3 |
| Mol.Wt. | 273.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014851 |
| CAS No | NA |
| Mol.F. | C14H19N3O |
| Mol.Wt. | 245.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014852 |
| CAS No | NA |
| Mol.F. | C16H15F3N2O5 |
| Mol.Wt. | 372.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014853 |
| CAS No | NA |
| Mol.F. | C22H25FN4O5 |
| Mol.Wt. | 444.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014854 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |